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ABSTRACT
orldwide, cervical cancer is one of the 
common cancers among women and it has 
been considered as one of the greatest W
threats to women's lives1. Every year, cancer causes 
almost fifty-one million deaths among women out of 
which cervical cancer is the third commonest and is 
responsible for almost 9% of the new cancer cases and 
2,38% of the total cancer death . 
Unfortunately, 85% of cervical cancer occurs in the low 
4and middle income countries . In 2008 alone, 
proportion of women who died from cervical cancer 
was 275,100 globally and more than 85% of them 
2occurred in developing countries .  Human 
papillomavirus (HPV) has already been documented 
as the most common sexually transmitted infection 
throughout the world and is also primary the cause of 
5cervical cancer .  About 50% – 80% of women who are 
sexually active have had the HPV infection at least once 
5in their lifetime . 
An efficient screening program has contributed to 
significant reduction of cervical cancer in many 
developed nations. However, the uptake of screening is 
low ranging from 0.4% – 20.2% in developing 
6countries . Reasons given for the low uptake include 
INTRODUCTION
BACKGROUND
Cervical cancer, commonest among cancers of the female genital tract continued to pose major challenge to 
women of reproductive age in developing countries though infection by its causative agent, human papilloma virus 
(HPV) is preventable. This study aimed to assess awareness and attitude of market women concerning HPV and its 
vaccines in prevention of cervical cancer. 
MATERIALS AND METHODS
A cross sectional study involving 329 market women, using multistage sampling technique. Instrument was an 
Interviewer--administered questionnaire on socio-demographic characteristics, knowledge and awareness of HPV 
and its vaccine, sexual history and attitude towards HPV vaccines. Data analysis was done using SPSS version 20.0 
with statistical significance level set at p<0.05.
RESULTS
Mean age of respondents was 29.49±3.65 years. All respondents were sexually active with majority (94.8%) having 
multiple sexual partners. Awareness of HPV vaccine and Pap smear test was among 1.2% and 9.4% respectively. 
Attitude towards HPV vaccination was good in 304 (92.4%) with 302 (91.8%) willing to take the HPV vaccines. 
There was significant association between attitude towards HPV vaccine and willingness to take HPV vaccine 
CONCLUSIONS 
Awareness of HPV and its vaccines is low among market women in our community. Policies and actions to step up 
information dissemination are urgently needed in order to stem the scourge of cervical cancer in our society. 
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sample size of 329 is expected to give the study 
significant results and power of 80%.
The instrument was an interviewer-administered 
questionnaire which was validated and translated to 
the local language. It consists of 42 open and close 
ended questions and was divided into five sections: 
Socio-demographic characteristics of the participants, 
Knowledge and awareness of HPV, sexual history, 
knowledge of HPV vaccine, and Attitude towards the 
vaccine. In assessing knowledge, points were allocated 
to correct responses and the total points were 
converted to percentages. Respondents with less than 
30% were regarded as having poor knowledge. Data 
were analyzed using SPSS version 20.0. Tests of 
significance were done with p-value set at <0.05 while 
associations were determined using chi-square 
statistics. Ethics approval was obtained from Oyo state 
ethics committee. 
RESULTS
In this study, we aimed to determine the level of 
awareness of market women in our environment to 
HPV and its vaccines. We interviewed 329 market 
women and their social demographic characteristics 
are presented in table 1. The mean age of respondents 
was 29.5±3.7years with majority having secondary 
level of education and most of them are married. Only 
31(9.4%) have ever heard of Pap smear screening test 
for cervical cancer and only 4(1.2%) had ever heard of 
HPV out of which only 1 had a good knowledge. 
Almost all 30(96.8%) who have heard of Pap smear 
screening had the hospital or healthcare provider has 
their source of information as shown in table 2. All the 
respondents are sexually active with 312(94.8) 
currently having more than one sexual partner. None 
of our respondents has ever had Pap smear test done 
nor had vaccination against HPV.
About half of the respondents, 164 (49.8%), were 
sexually–active by age 18years and 9(2.7%) reported 
previous history of sexually transmitted infections 
(STIs) as presented in table 3. 
Table 4 shows that at the current price of the HPV 
vaccine and if the women are found eligible, only 
82(24.9%) will be willing to take the vaccine but with 
reduction in cost, 302 (91.8%) of the respondents 
indicated their readiness to be vaccinated.
A significant association was found between attitude 
towards vaccination and willingness to take HPV 
vaccination (χ2=111.8, p<0.001). 
low educational level, low acculturation, cost, 
unavailability and inaccessibility to services as well as 
lower cognitive scores with social, psychological and 
5,7-9demographic factors .
In most developing countries, knowledge of women 
about cervical cancer and screening tests is still very 
low. In a study conducted in the Southwestern part of 
Nigeria, awareness of HPV virus amongst women 
between 20 and 65 years was about 15% while over 50% 
of the population had no access to cervical cancer 
11screening .
The present approach to prevention of cervical cancer 
is directed towards either immunization against HPV 
infection before coitarche or screening for the presence 
12of pre-invasive lesions of the cervix . HPV vaccination 
may prevent HPV acquisition, regression of cervical 
dysplasia or warts, condylomata and high-grade 
squamous intraepithelial lesions thus reducing the 
morbidity and mortality related to HPV infection and 
13cervical cancer . In general, improvement of existing 
health services, awarenessabout cervical cancer, 
accessibility to effective HPV vaccination and 
screening programs could reduce the burden of 
3cervical cancer among women .
Market women form an essential economic main force 
in the nation and in this manner, it is imperative to 
know whether market women have adequate 
14information about HPV and HPV vaccination .
To our knowledge, very few previous studies have 
evaluated the attitude and awareness about HPV and 
HPV vaccine among market women of reproductive 
age. This study was therefore conducted to assess 
awareness and attitude of market women in Ibadan, 
Nigeria towards HPV vaccine and its uptake.
MATERIALS AND METHODS
This was a questionnaire based cross-sectional study 
conducted between January and March 2015 among 
market women aged 18 years and above in the largest 
cosmopolitan open market located in the heart of 
Ibadan.
Bodija Market represents various socio-demographic 
groups of female traders in Ibadan. It has 15 blocks 
which was divided into 3596 stalls with some other 
traders displaying their wares by the roadside. Three of 
the blocks were randomly selected and female traders 
in every 4th stall, who satisfied the inclusion criteria, 
were selected using systematic random sampling.  
Only consenting female traders were interviewed and 
participants were randomly selected where there is 
more than one eligible female trader. A minimum 
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to prevalence of cervical cancer, it is pertinent to note 
that more of our respondents are already at higher 
risks. There is therefore an urgent need to ensure an 
effective cervical cancer screening program for these 
women.
The study found that low awareness has little or no 
impact on respondents' attitudes towards HPV 
vaccination. The study also revealed that respondents 
are well acquainted with the relevance and importance 
of vaccination. However, there is more to do as far as 
sensitization and awareness are concern.
CONCLUSION
A high proportion of the female traders in Bodija 
Market, Ibadan were yet unaware of HPV and HPV 
vaccination, despite their high risk sexual behaviour. In 
waging war against cervical cancer, additional efforts 
need to be put into educating the public about its 
prevention. It is also expedient for Government and 
Non-Governmental Organizations including donor 
agencies to ensure that HPV vaccination is readily 
available and accessible to women in an affordable 
manner.
DISCUSSION 
The study was conducted to assess the awareness and 
attitude of market women toward HPV vaccination. 
The findings from this study demonstrated a very low 
awareness about HPV vaccination among market 
women in our community. This value is far lower than 
19.7% and 68.6% reported in Lagos and Kaduna 
respectively among similar group of women 
apparently because of the cosmopolitan nature of these 
14,15two towns .
The study further showed that awareness of Pap smear 
was significantly higher than that of HPV vaccination.  
Although the media is a good means of dissemination 
of information, none of the women in the study 
indicated to have received information from the media. 
This calls for media training and education on HPV 
12vaccination .  Findings from previous studies 
corroborate the findings from this study where most of 
14,16,17the respondents had little or no awareness of HPV . 
Those who were aware reportedly received the 
information on HPV from hospitals and health care 
providers. Therefore, low awareness can also be related 
to poor health- seeking behaviour. 
In consideration to the association of early coitarche, 
low socio economic status and multiple sexual partners 
Table 1: Socio-demographic characteristics of participants
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Table 2: Awareness of HPV and awareness of Pap smear
Variable Frequency (329) Percent 






























Source of information of 













Table 3: Sexual history of participants
Questions Frequency Percent 












Age at first sexual 
intercourse 
< 18 years 
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Table 4: Willingness to take and attitude towards HPV vaccination
Variable Frequency Percent 
Willingness to be 
























If HPV vaccine is free or at a lower cost, 


























Would you let your 9-14 year old sibling 












The cost is ten thousand naira, would 


















Pvalue Good(%) Poor (%) 
Willingness 
































Nigerian Journal of Medicine, Vol. 25 No. 1, January - March, 2016, ISSN 1115-2613
16
Sweden. J. Psychosom. Obstet. Gynaecol. 
(2008). Vol. 29(1):23–31.   
11. Abiodun O A, Fatungase OKand Olu-Abiodun 
OO. Knowledge, perception and predictors of 
uptake of cervical screening among rural 
Niger ian  women.  J .  Pub l i c  Hea l th  
Epidemiol.(2014).Vol 6(3): 119-124
12. Ugwu E O, Obi S N, Ezechukwu P C, Okafor I I, 
Ugwu A O.Acceptability of human papilloma 
virus vaccine and cervical cancer screening 
among female health-care workers in Enugu, 
Southeast Nigeria. Niger J ClinPract; (2013) 
Vol.16: 249-252.
13. Minhat, HS, Mustafa  J and  Sarabi 
S.Sociodemographic Determinants of 
Knowledge on HPV Vaccination among 
Iranian Women Living in Malaysia. Academic 
Journal of Cancer Research (2013)6 (1): 08-12
14. Ahmed SA, Sabitu K, Idris SH, Ahmed R. 
Knowledge, attitude and practice of cervical 
cancer screening among market women in 
Zaria, Nigeria. Niger Med J (2013);54:316-319
15. Ezenwa BN, Balogun MR, Okafor IP. Mothers' 
human papilloma virus knowledge and 
willingness to vaccinate their adolescent 
daughters in Lagos, Nigeria. Int J Womens 
Health (2013); 5: 371-377.
16. Marlow LA, Forster AS, Wardle J, Walker J. 
Mothers'and adolescents' beliefs about risk 
compensation following HPV vaccination. J 
Adolesc Health (2009) Vol. 444(5): 446-451
17. Waller J, McCaffery KJ, Forrest S, Szarewski A, 
Cadman L, Wardle J. Awareness of human 
papillomavirus among women attending a 
well clinic. Sex Transm Infect (2003); 79(4): 320-
322.
REFERENCES
1. Cunningham MS, Skrastins E, Fitzpatrick R, 
Jindal P, Oneko O, Yeates K et al. Cervical 
cancer  screening and HPV vaccine  
acceptability among rural and urban women 
in Kilimanjaro Region, Tanzania. BMJ Open 
2015;5:e005828. doi:10.1136/bmjopen-2014
2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, 
Eser S, Mathers C, Rebelo M, Parkin DM, 
Forman D, Bray, F (2013). GLOBOCAN 2012 
v1.0, Cancer Incidence and Mortality 
Worldwide: IARC CancerBase No. 11 
[Internet]. Lyon, France: International Agency 
for Research on Cancer. Available from 
 and accessed on 14th 
October, 2015
3. Nnodu   O, Erinosho  L, Jamda   M, Olaniyi   O, 
Adelaiye  R, Lawson  L et al. Knowledge and 
Attitudes towards Cervical Cancer and 
Human Papillomavirus: A Nigerian Pilot 
Study. Afr. J.Reprod. Health (2010). Vol.14(1): 
95-108 
4. Oche MO, Kaoje AU, Gana G, Ango GT Cancer 
of the cervix and cervical screening: Current 
knowledge, attitude and practices of female 
health workers in Sokoto, Nigeria. Int. J. Med. 
Med. Sci. (2013). Vol.5(4):184-190
5. Wright KO, Aiyedehin O, Akinyinka MR, and 
Ilozumba O, “Cervical Cancer: Community 
Perception and Preventive Practices in an 
Urban Neighborhood of Lagos (Nigeria),” 
ISRN Preventive Medicine, vol. 2014, Article 
I D  9 5 0 5 3 4 ,  9  p a g e s ,  2 0 1 4 .          
doi:10.1155/2014/950534 
6. Louie KS, De Sanjose S, and Mayaud P, 
“Epidemiology and prevention of human 
papillomavirus and cervical cancer in sub-
Saharan Africa: a comprehensive review,” 
Tropical Medicine and International Health 
(2009). Vol. 14(10):1287–1302
7. Wolff M, Bates T, Beck B, Young S, Ahmed S, 
Maurana C. Cancer prevention in underserved 
African American communities: barriers and 
effective strategies—a review of the literature. 
WMJ (2003).  10:36-40. 
8.  Wu Z, Black S, Markides K. Prevalence and 
associated factors of cancer screening: Why are 
so many older Mexican-American women 
never screened? Prev. Med. (2001).  33:268-273.
9. Coronado GD, Thompson B, Koepsell TD, 
Schwartz SM, McLerran D. Use of Pap test 
among Hispanics and Non-Hispanic whites 
ina rural setting. Prev. Med. (2004). 38:713-2. 
10. Oscarsson MG, Benzein EG, Wijma BE. 
Reasons for nonattendance at cervical 
screening as reported by non-attendees in 
http://globocan.iarc.fr
Nigerian Journal of Medicine, Vol. 25 No. 1, January - March, 2016, ISSN 1115-2613
17
